Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Short report

A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoter

Authors: Laurent Mailly, Charlotte Boulade-Ladame, Georges Orfanoudakis, François Deryckere

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

The construction of expression vectors derived from the human adenovirus type 5 (Ad5), usually based on homologous recombination, is time consuming as a shuttle plasmid has to be selected before recombination with the viral genome. Here, we describe a method allowing direct cloning of a transgene in the E3 region of the Ad5 genome already containing the immediate early CMV promoter upstream of three unique restriction sites. This allowed the construction of recombinant adenoviral genomes in just one step, reducing considerably the time of selection and, of course, production of the corresponding vectors. Using this vector, we produced recombinant adenoviruses, each giving high-level expression of the transgene in the transduced cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M: Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996,70(7):4805-4810.PubMedCentralPubMed Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M: Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996,70(7):4805-4810.PubMedCentralPubMed
2.
go back to reference He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998,95(5):2509-2514. 10.1073/pnas.95.5.2509PubMedCentralCrossRefPubMed He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998,95(5):2509-2514. 10.1073/pnas.95.5.2509PubMedCentralCrossRefPubMed
3.
go back to reference Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983,166(4):557-580. 10.1016/S0022-2836(83)80284-8CrossRefPubMed Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983,166(4):557-580. 10.1016/S0022-2836(83)80284-8CrossRefPubMed
4.
go back to reference Renaut L, Bernard C, D'Halluin JC: A rapid and easy method for production and selection of recombinant adenovirus genomes. J Virol Methods 2002,100(1-2):121-131. 10.1016/S0166-0934(01)00407-4CrossRefPubMed Renaut L, Bernard C, D'Halluin JC: A rapid and easy method for production and selection of recombinant adenovirus genomes. J Virol Methods 2002,100(1-2):121-131. 10.1016/S0166-0934(01)00407-4CrossRefPubMed
5.
go back to reference Mizuguchi H, Kay MA: Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 1998,9(17):2577-2583. 10.1089/hum.1998.9.17-2577CrossRefPubMed Mizuguchi H, Kay MA: Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 1998,9(17):2577-2583. 10.1089/hum.1998.9.17-2577CrossRefPubMed
6.
go back to reference Mizuguchi H, Kay MA: A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum Gene Ther 1999,10(12):2013-2017. 10.1089/10430349950017374CrossRefPubMed Mizuguchi H, Kay MA: A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum Gene Ther 1999,10(12):2013-2017. 10.1089/10430349950017374CrossRefPubMed
7.
go back to reference Mizuguchi H, Kay MA, Hayakawa T: In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors. Biotechniques 2001,30(5):1112-4, 1116.PubMed Mizuguchi H, Kay MA, Hayakawa T: In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors. Biotechniques 2001,30(5):1112-4, 1116.PubMed
8.
go back to reference Nomine Y, Masson M, Charbonnier S, Zanier K, Ristriani T, Deryckere F, Sibler AP, Desplancq D, Atkinson RA, Weiss E, Orfanoudakis G, Kieffer B, Trave G: Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell 2006,21(5):665-678. 10.1016/j.molcel.2006.01.024CrossRefPubMed Nomine Y, Masson M, Charbonnier S, Zanier K, Ristriani T, Deryckere F, Sibler AP, Desplancq D, Atkinson RA, Weiss E, Orfanoudakis G, Kieffer B, Trave G: Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell 2006,21(5):665-678. 10.1016/j.molcel.2006.01.024CrossRefPubMed
9.
go back to reference Mathis C, Hindelang C, LeMeur M, Borrelli E: A transgenic mouse model for inducible and reversible dysmyelination. J Neurosci 2000,20(20):7698-7705.PubMed Mathis C, Hindelang C, LeMeur M, Borrelli E: A transgenic mouse model for inducible and reversible dysmyelination. J Neurosci 2000,20(20):7698-7705.PubMed
10.
go back to reference Mailly L, Renaut L, Rogee S, Grellier E, D'Halluin JC, Colin M: Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21. Mol Ther 2006,14(2):293-304. 10.1016/j.ymthe.2006.03.017CrossRefPubMed Mailly L, Renaut L, Rogee S, Grellier E, D'Halluin JC, Colin M: Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21. Mol Ther 2006,14(2):293-304. 10.1016/j.ymthe.2006.03.017CrossRefPubMed
11.
go back to reference Lagrange M, Charbonnier S, Orfanoudakis G, Robinson P, Zanier K, Masson M, Lutz Y, Trave G, Weiss E, Deryckere F: Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J Gen Virol 2005,86(Pt 4):1001-1007. 10.1099/vir.0.80607-0CrossRefPubMed Lagrange M, Charbonnier S, Orfanoudakis G, Robinson P, Zanier K, Masson M, Lutz Y, Trave G, Weiss E, Deryckere F: Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J Gen Virol 2005,86(Pt 4):1001-1007. 10.1099/vir.0.80607-0CrossRefPubMed
12.
go back to reference Lagrange M, Boulade-Ladame C, Mailly L, Weiss E, Orfanoudakis G, Deryckere F: Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells. Biochem Biophys Res Commun 2007,361(2):487-492. 10.1016/j.bbrc.2007.07.040CrossRefPubMed Lagrange M, Boulade-Ladame C, Mailly L, Weiss E, Orfanoudakis G, Deryckere F: Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells. Biochem Biophys Res Commun 2007,361(2):487-492. 10.1016/j.bbrc.2007.07.040CrossRefPubMed
Metadata
Title
A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoter
Authors
Laurent Mailly
Charlotte Boulade-Ladame
Georges Orfanoudakis
François Deryckere
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-73

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.